Company Valuation: JHS Svendgaard Laboratories Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Market Cap 1 459.8 1,288 1,334 1,006 1,266 957.1
Change - 180.12% 3.55% -24.57% 25.86% -24.41%
Enterprise Value (EV) 1 483.2 1,128 1,315 770.7 1,216 836.5
Change - 133.39% 16.63% -41.41% 57.78% -31.21%
P/E -23.2x 102x -32.6x -6.62x -8.19x -4.71x
PBR 0.26x 0.68x 0.72x 0.58x 0.75x 0.55x
PEG - -1x 0x -0x 0.5x -0.2x
Capitalization / Revenue 0.32x 1.28x 1.55x 0.98x 1.74x 1.04x
EV / Revenue 0.34x 1.12x 1.52x 0.75x 1.67x 0.91x
EV / EBITDA 10.8x 18.6x 93.7x -67.8x 95x -23.5x
EV / EBIT -16.6x 317x -28.6x -11x -26.8x -7.69x
EV / FCF -2.87x -248x 6.65x 1.85x -3.77x -7.82x
FCF Yield -34.9% -0.4% 15% 54% -26.5% -12.8%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.325 0.1952 -0.63 -2.34 -1.973 -2.374
Distribution rate - - - - - -
Net sales 1 1,416 1,010 862.5 1,026 728.9 922.9
EBITDA 1 44.8 60.48 14.03 -11.37 12.8 -35.67
EBIT 1 -29.16 3.554 -46.05 -69.82 -45.42 -108.8
Net income 1 -19.79 11.98 -40.52 -154.6 -154.6 -197.4
Net Debt 1 23.4 -160.3 -18.37 -235.3 -50.11 -120.6
Reference price 2 7.550 20.000 20.550 15.500 16.150 11.180
Nbr of stocks (in thousands) 60,900 64,400 64,900 64,900 78,397 85,604
Announcement Date 7/17/20 9/6/21 9/9/22 9/5/23 8/16/24 8/28/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
15.96x2.53x11.64x4.62% 37.11B
21.57x1.48x8.69x2.2% 10.9B
9.87x1.01x5.88x6.72% 3.52B
18.1x3.2x11.95x2.33% 2.68B
23.52x0.82x9.02x1.56% 1.39B
15.79x - - 4.92% 939M
23.99x - - 3.29% 767M
Average 18.40x 1.81x 9.44x 3.66% 8.19B
Weighted average by Cap. 17.04x 2.22x 10.65x 4.1%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. JHS Stock
  4. JHS Stock
  5. Valuation JHS Svendgaard Laboratories Limited